[go: up one dir, main page]

NO995646L - Fremgangsmåte for å oeke utbyttet av nukleosidanaloger - Google Patents

Fremgangsmåte for å oeke utbyttet av nukleosidanaloger

Info

Publication number
NO995646L
NO995646L NO995646A NO995646A NO995646L NO 995646 L NO995646 L NO 995646L NO 995646 A NO995646 A NO 995646A NO 995646 A NO995646 A NO 995646A NO 995646 L NO995646 L NO 995646L
Authority
NO
Norway
Prior art keywords
yield
increasing
nucleoside analogs
nucleoside
analogs
Prior art date
Application number
NO995646A
Other languages
English (en)
Other versions
NO995646D0 (no
NO313096B1 (no
Inventor
Michael David Goodyear
P Owen Dwyer
Malcolm Leithead Hill
Andrew Jonathan Whitehead
Roy Hornby
Peter Hallett
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267157&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO995646(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9408112A external-priority patent/GB9408112D0/en
Priority claimed from GB9408091A external-priority patent/GB9408091D0/en
Priority claimed from GB9408103A external-priority patent/GB9408103D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO995646D0 publication Critical patent/NO995646D0/no
Publication of NO995646L publication Critical patent/NO995646L/no
Publication of NO313096B1 publication Critical patent/NO313096B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO19995646A 1994-04-23 1999-11-17 Fremgangsmåte for å öke utbyttet av nukleosidanaloger NO313096B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9408112A GB9408112D0 (en) 1994-04-23 1994-04-23 Process
GB9408091A GB9408091D0 (en) 1994-04-23 1994-04-23 Process
GB9408103A GB9408103D0 (en) 1994-04-23 1994-04-23 Chemical compounds
PCT/EP1995/001503 WO1995029174A1 (en) 1994-04-23 1995-04-21 Process for the diastereoselective synthesis of nucleoside analogues

Publications (3)

Publication Number Publication Date
NO995646D0 NO995646D0 (no) 1999-11-17
NO995646L true NO995646L (no) 1999-11-17
NO313096B1 NO313096B1 (no) 2002-08-12

Family

ID=27267157

Family Applications (2)

Application Number Title Priority Date Filing Date
NO964487A NO307179B1 (no) 1994-04-23 1996-10-22 Stereoselektiv fremgangsmåte for fremstilling av nukleosidanaloger og salicylatsalt derav
NO19995646A NO313096B1 (no) 1994-04-23 1999-11-17 Fremgangsmåte for å öke utbyttet av nukleosidanaloger

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO964487A NO307179B1 (no) 1994-04-23 1996-10-22 Stereoselektiv fremgangsmåte for fremstilling av nukleosidanaloger og salicylatsalt derav

Country Status (30)

Country Link
US (2) US6051709A (no)
EP (1) EP0757684B1 (no)
JP (2) JP4056558B2 (no)
KR (1) KR100241842B1 (no)
CN (2) CN1151146C (no)
AP (1) AP704A (no)
AT (1) ATE181326T1 (no)
AU (1) AU696612B2 (no)
BG (1) BG62810B1 (no)
BR (1) BR9507499A (no)
CZ (1) CZ293827B6 (no)
DE (1) DE69510347T2 (no)
DK (1) DK0757684T3 (no)
EE (1) EE03442B1 (no)
ES (1) ES2133769T3 (no)
FI (1) FI120401B (no)
GR (1) GR3031043T3 (no)
HK (1) HK1004221A1 (no)
HU (1) HU218044B (no)
IL (1) IL113432A (no)
IS (1) IS1844B (no)
NO (2) NO307179B1 (no)
NZ (1) NZ285396A (no)
PL (1) PL180090B1 (no)
RO (2) RO117916B1 (no)
RU (1) RU2158736C2 (no)
SK (1) SK281327B6 (no)
TW (1) TW487704B (no)
UA (1) UA43362C2 (no)
WO (1) WO1995029174A1 (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6175008B1 (en) * 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues
BR9510327A (pt) * 1994-10-22 1998-11-10 Chong Kun Dang Corp Derivados de nucleosídeos e seu processo de preparo
GB9506644D0 (en) * 1995-03-31 1995-05-24 Wellcome Found Preparation of nucleoside analogues
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
PT1104415E (pt) * 1998-08-12 2005-03-31 Univ Emory Metodo de preparacao de nucleosidos de 1,3-oxatiolano
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
WO2002070518A1 (en) * 2001-03-01 2002-09-12 Triangle Pharmaceuticals, Inc. Polymorphic and other crystalline forms of cis-ftc
CA2351049C (en) 2001-06-18 2007-03-13 Brantford Chemicals Inc. Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers
WO2003027106A1 (en) * 2001-09-25 2003-04-03 Cadila Healthcar Limited Process for the preparation of crystalline polymorph ii of lamivudine
ITMI20030578A1 (it) * 2003-03-24 2004-09-25 Clariant Lsm Italia Spa Processo ed intermedi per la preparazione di emtricitabina
US20050187913A1 (en) 2003-05-06 2005-08-25 Yoram Nelken Web-based customer service interface
CN101307048B (zh) * 2007-05-18 2011-03-23 上海迪赛诺医药发展有限公司 立体选择性制备拉米夫定的方法
WO2009037538A2 (en) * 2007-09-17 2009-03-26 Aurobindo Pharma Ltd Process for the preparation of lamivudine form i
EP2048151A1 (en) * 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
BRPI0820226A2 (pt) * 2007-11-29 2015-06-16 Ranbaxy Lab Ltd Processo para o preparo de um 1,3-oxatiolana, para o preparo de lamivudina e para isolar lamivudina, lamivudina e composição farmacêutica
WO2009069013A1 (en) * 2007-11-29 2009-06-04 Ranbaxy Laboratories Limited Crystalline form i of lamivudine and its preparation
US20100311961A1 (en) * 2007-11-29 2010-12-09 Ranbaxy Laboratories Limited Process and intermediates for the preparation of substituted 1,3-oxathiolanes, especially lamivudine
WO2009084033A2 (en) * 2007-12-07 2009-07-09 Matrix Laboratories Limited Process for producing 5-fluoro-1-(2r,5s)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yi]cytosine
CN101391997B (zh) * 2008-09-18 2010-12-22 江苏科本医药化学有限公司 一种恩曲他滨中间体的合成方法
CN101362752B (zh) * 2008-09-18 2011-12-28 浙江教育学院 一种拉米夫定中间体的合成方法
US20110282046A1 (en) 2009-01-19 2011-11-17 Rama Shankar Process for preparation of cis-nucleoside derivative
KR101474570B1 (ko) 2009-04-13 2014-12-19 주식회사 대희화학 라미부딘의 신규한 중간체 및 이의 제조방법
CN101544632B (zh) * 2009-04-24 2011-09-07 湖南千金湘江药业股份有限公司 拉米夫定非对映选择合成方法
EP2488516B1 (en) 2009-10-14 2015-04-01 Mylan Laboratories Limited Process for the preparation of lamivudine and novel salts in the manufacture thereof
EP3494972B1 (en) 2010-01-27 2023-12-13 VIIV Healthcare Company Combinations of dolutegravir and lamivudine for the treatment of hiv infection
WO2011095987A1 (en) 2010-02-03 2011-08-11 Matrix Laboratories Ltd. Novel process for the preparation of cis-nucleoside derivative
CN102167696B (zh) 2010-02-25 2013-09-18 南京正大天晴制药有限公司 拉米夫定草酸盐及其制备方法
AU2011222471B2 (en) 2010-03-04 2014-07-31 Sun Pharmaceutical Industries Limited A process for stereoselective synthesis of 5-fluoro-1-(2R,5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
CN101830893A (zh) * 2010-05-31 2010-09-15 安徽一帆香料有限公司 一种拉米夫定中间体hdms的合成制备工艺
CN102399213A (zh) * 2010-09-08 2012-04-04 重庆医药工业研究院有限责任公司 拉米夫定单邻苯二甲酸盐及其合成方法
CN103221037A (zh) 2010-11-12 2013-07-24 葛兰素惠尔康制造业私人有限公司 新药物组合物
US9650346B2 (en) 2011-04-08 2017-05-16 Laurus Labs Private Ltd. Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof
CN102796088B (zh) * 2012-05-21 2015-06-10 湖南千金湘江药业股份有限公司 一种拉米夫定的制备方法
CN103450166A (zh) * 2012-05-31 2013-12-18 上海迪赛诺药业有限公司 制备核苷化合物的方法
CN103864835A (zh) * 2013-03-26 2014-06-18 安徽贝克联合制药有限公司 一种提高拉米夫定中间体立体选择性制备方法
CN103288806A (zh) * 2013-07-02 2013-09-11 山东大学 一种曲沙他滨的合成方法
CN103694231A (zh) * 2013-11-28 2014-04-02 安徽一帆香料有限公司 一种拉米夫定中间体hdms的合成制备方法
US9571109B2 (en) * 2015-03-27 2017-02-14 International Business Machines Corporation Voltage controlled oscillator runaway prevention
CN106146481A (zh) * 2015-04-07 2016-11-23 江苏普信制药有限公司 一种核苷类似物的制备方法
CN105037340B (zh) * 2015-07-14 2018-08-10 福建广生堂药业股份有限公司 一种拉米夫定关键中间体手性异构体杂质的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US6175008B1 (en) * 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
PT674634E (pt) * 1989-02-08 2003-09-30 Iaf Biochem Int Processos para preparar 1,3-oxatiolanos substituidos com propriedades antivirais
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
US5587480A (en) * 1990-11-13 1996-12-24 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
DE19875016I2 (de) 1991-05-16 2004-07-01 Glaxo Group Ltd Nukleosidanalogen enthaltende Antiviren-Zubereitungen.
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues

Also Published As

Publication number Publication date
UA43362C2 (uk) 2001-12-17
HK1004221A1 (en) 1998-11-20
IL113432A0 (en) 1995-07-31
KR100241842B1 (ko) 2000-03-02
BR9507499A (pt) 1997-09-23
JPH10502615A (ja) 1998-03-10
NO307179B1 (no) 2000-02-21
CN1149871A (zh) 1997-05-14
EP0757684B1 (en) 1999-06-16
AU696612B2 (en) 1998-09-17
CZ309696A3 (en) 1997-04-16
AP704A (en) 1998-12-04
NO995646D0 (no) 1999-11-17
PL316904A1 (en) 1997-02-17
JP2007217425A (ja) 2007-08-30
SK281327B6 (sk) 2001-02-12
DE69510347T2 (de) 1999-11-18
HU9602925D0 (en) 1996-12-30
EE9600134A (et) 1997-04-15
CN1151146C (zh) 2004-05-26
HUT76296A (en) 1997-07-28
NO964487L (no) 1996-12-17
NZ285396A (en) 1998-10-28
BG62810B1 (bg) 2000-08-31
BG100916A (en) 1997-07-31
WO1995029174A1 (en) 1995-11-02
JP4056558B2 (ja) 2008-03-05
FI964251A0 (fi) 1996-10-22
EE03442B1 (et) 2001-06-15
SK135596A3 (en) 1997-07-09
ATE181326T1 (de) 1999-07-15
IS1844B (is) 2003-01-30
DE69510347D1 (de) 1999-07-22
CZ293827B6 (cs) 2004-08-18
CN1290841C (zh) 2006-12-20
NO964487D0 (no) 1996-10-22
NO313096B1 (no) 2002-08-12
RO117916B1 (ro) 2002-09-30
RU2158736C2 (ru) 2000-11-10
US6329522B1 (en) 2001-12-11
AP9600871A0 (en) 1996-10-31
EP0757684A1 (en) 1997-02-12
US6051709A (en) 2000-04-18
FI120401B (fi) 2009-10-15
RO118714B1 (ro) 2003-09-30
DK0757684T3 (da) 2000-01-17
HU218044B (hu) 2000-05-28
GR3031043T3 (en) 1999-12-31
PL180090B1 (pl) 2000-12-29
IL113432A (en) 2000-11-21
CN1500782A (zh) 2004-06-02
FI964251L (fi) 1996-10-22
ES2133769T3 (es) 1999-09-16
AU2447195A (en) 1995-11-16
IS4366A (is) 1996-09-27
TW487704B (en) 2002-05-21

Similar Documents

Publication Publication Date Title
NO995646D0 (no) Fremgangsmåte for å öke utbyttet av nukleosidanaloger
EE03354B1 (et) Asendatud sulfoksiidide sünteesi protsess
FI973281L (fi) Menetelmä tiettyjen atsasykloheksapeptidien valmistamiseksi
FI945441A0 (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
NO963785D0 (no) Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser
NO944871L (no) Fremgangsmåte for fremstilling av polydimetylsiloksaner
FI953899A0 (fi) Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi
ITTO960495A0 (it) Procedimento per accrescere il flusso per elettrotrasporto di polipep-tidi.
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
IT1272922B (it) Procedimento per la preparazione di composti metallocenici
ITMI940317A0 (it) Procedimento per la produzione di gamma-butirrolattone
FI972065A0 (fi) Menetelmä N-fosfonometyyliglysiinin valmistamiseksi
FI945322L (fi) Menetelmä 2',3'-didehydro-2',3'-dideoksinukleosidien laajamittaista valmistusta varten
ITMI921157A0 (it) Processo per la preparazione di alchilpoliglucosidi
NO963187D0 (no) Fremgangsmåte for syntese av gamma-pyroner
FI955830L (fi) Menetelmä alkyylihalogeenidifluoriasetaattien valmistamiseksi
FI955856L (fi) Menetelmä sokereiden dekarbonyloimiseksi
IT1290151B1 (it) Procedimento migliorato per la produzione di 5-idrossimetiltiazolo
DE69320475D1 (de) Process for producing normal olefins
ITMI951556A0 (it) Processo per la preparazione di fluorossi- o clorossi- perfluoroacilfluoruri
NO951060D0 (no) Prostaglandin F-estere
FI971964A0 (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi
ITMI941144A0 (it) Procedimento per la formazione di timbri
FI951441L (fi) Menetelmä 5-formyyliamino-pyrimidiinien valmistamiseksi
ITMI921348A0 (it) Processo per la preparazione di eseretolo

Legal Events

Date Code Title Description
MK1K Patent expired